Life Scientist > Lab Technology

Baker Institute spin-off enters agreement

20 June, 2005 by Susan Williamson

V-Kardia, the first spin-off company from the Baker Heart Research Institute in Melbourne, has entered into an agreement with Californian-based molecular cardiology company, Celladon, to develop and supply its V-Focus device for percutaneous delivery of gene therapy for congestive heart failure.


Taskforce to advise government on investment in medical research

20 June, 2005 by Susan Williamson

The federal government has set up the Private Sector Investment Taskforce to come up with strategies to gain more support for Australian researchers from business and philanthropic funds, both in Australia and overseas.


Believe the hype

20 June, 2005 by Graeme O'Neill

Is RNAi the real deal? Graeme O'Neill asked Australian scientist and global authority John Mattick.


Dreams, reality and commercialisation

20 June, 2005 by Keith Williams

Keith Williams reflects on the long and winding road he has travelled as a player in the filed of protein science.


Committee for Melbourne report calls for action

16 June, 2005 by Ruth Beran

Victoria won't meet its objective of becoming a top five global biotech location by 2010 if Victorian biotech companies fail to attract expansion capital, according to a report released today by the Committee for Melbourne (CfM).


Funding for ARC centres of excellence and federation fellowships

15 June, 2005 by Susan Williamson

Eleven new ARC centres of excellence and 24 federation fellowship receipients will share $162 million in federal government funding.


Victorian Premier presents Award for Medical Research

14 June, 2005 by Ruth Beran

Two Melbourne researchers, Dr Merlin Thomas and Dr Stephen Ting, have jointly won the 2005 Victorian Premier's Award for Medical Research.


Two PhD students win inaugural Qiagen prize

09 June, 2005 by Ruth Beran

Two PhD students at the University of Melbourne's Department of Microbiology and Immunology were today awarded cash prizes towards travel to an international conference by life science company Qiagen.


ASMR president rallies for medical research funding

09 June, 2005 by Susan Williamson

The president of the Australian Society for Medical Research has made a call for action from researchers to campaign for more federal government funding for medical research.


Let's end restrictions on science: ASMR medallist

09 June, 2005 by Susan Williamson

The message from this year's Australian Society for Medical Research medallist, Julian Savulescu, was controversial but clear: we should use science to enhance humans.


Bio21 Institute opens today

08 June, 2005 by Ruth Beran

Australia's newest research institute, the AUD$100 million Bio21 Institute, based at the University of Melbourne, officially opened its doors today.


Australian, Japanese synchrotrons to partner

07 June, 2005 by Ruth Beran

Japan's SPring-8, the world's largest synchrotron, has signed a new partnership with the Australian Synchrotron to share expertise and develop new technology.


Research Australia calls on govt to ramp up funding

06 June, 2005 by Ruth Beran

Australia must ramp up its investment in health and medical research to ensure its future prosperity, said Research Australia CEO Dr Christine Bennett and Australian Graduate School of Management professor Michael Vitale in a joint paper published this week in the Medical Journal of Australia.


We're open for business: CSIRO exec

06 June, 2005 by Ruth Beran

The new executive director of CSIRO's business development team, Nigel Poole, is on the campaign trail, seeking to convince the business world that the organisation is open for business.


Board changes at Bone

03 June, 2005 by Staff Writers

Former AustCancer CEO Paul Hopper has joined the board of Perth-based Bone Medical (ASX:BNE), among other changes at the company, including the resignation of Michael Perrott from the board.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd